IBDEI0GC ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7075,1,3,0)
 ;;=3^Primary Hyperaldosteronism NEC
 ;;^UTILITY(U,$J,358.3,7075,1,4,0)
 ;;=4^E26.09
 ;;^UTILITY(U,$J,358.3,7075,2)
 ;;=^5002735
 ;;^UTILITY(U,$J,358.3,7076,0)
 ;;=E78.00^^58^463^6
 ;;^UTILITY(U,$J,358.3,7076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7076,1,3,0)
 ;;=3^Pure Hypercholesterolemia,Unspec
 ;;^UTILITY(U,$J,358.3,7076,1,4,0)
 ;;=4^E78.00
 ;;^UTILITY(U,$J,358.3,7076,2)
 ;;=^5138435
 ;;^UTILITY(U,$J,358.3,7077,0)
 ;;=E78.01^^58^463^3
 ;;^UTILITY(U,$J,358.3,7077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7077,1,3,0)
 ;;=3^Familial Hypercholesterolemia,Unspec
 ;;^UTILITY(U,$J,358.3,7077,1,4,0)
 ;;=4^E78.01
 ;;^UTILITY(U,$J,358.3,7077,2)
 ;;=^7570555
 ;;^UTILITY(U,$J,358.3,7078,0)
 ;;=E78.41^^58^463^2
 ;;^UTILITY(U,$J,358.3,7078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7078,1,3,0)
 ;;=3^Elevated Lipoprotein(a)
 ;;^UTILITY(U,$J,358.3,7078,1,4,0)
 ;;=4^E78.41
 ;;^UTILITY(U,$J,358.3,7078,2)
 ;;=^5157298
 ;;^UTILITY(U,$J,358.3,7079,0)
 ;;=E78.49^^58^463^4
 ;;^UTILITY(U,$J,358.3,7079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7079,1,3,0)
 ;;=3^Hyperlipidemia,Other
 ;;^UTILITY(U,$J,358.3,7079,1,4,0)
 ;;=4^E78.49
 ;;^UTILITY(U,$J,358.3,7079,2)
 ;;=^5157299
 ;;^UTILITY(U,$J,358.3,7080,0)
 ;;=H91.8X9^^58^464^1
 ;;^UTILITY(U,$J,358.3,7080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7080,1,3,0)
 ;;=3^Hearing Loss,Unspec Ear
 ;;^UTILITY(U,$J,358.3,7080,1,4,0)
 ;;=4^H91.8X9
 ;;^UTILITY(U,$J,358.3,7080,2)
 ;;=^5133555
 ;;^UTILITY(U,$J,358.3,7081,0)
 ;;=H93.13^^58^464^2
 ;;^UTILITY(U,$J,358.3,7081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7081,1,3,0)
 ;;=3^Tinnitus,Bilateral
 ;;^UTILITY(U,$J,358.3,7081,1,4,0)
 ;;=4^H93.13
 ;;^UTILITY(U,$J,358.3,7081,2)
 ;;=^5006966
 ;;^UTILITY(U,$J,358.3,7082,0)
 ;;=H93.19^^58^464^3
 ;;^UTILITY(U,$J,358.3,7082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7082,1,3,0)
 ;;=3^Tinnitus,Unspec Ear
 ;;^UTILITY(U,$J,358.3,7082,1,4,0)
 ;;=4^H93.19
 ;;^UTILITY(U,$J,358.3,7082,2)
 ;;=^5006967
 ;;^UTILITY(U,$J,358.3,7083,0)
 ;;=K21.0^^58^465^4
 ;;^UTILITY(U,$J,358.3,7083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7083,1,3,0)
 ;;=3^GERD w/ Esophagitis
 ;;^UTILITY(U,$J,358.3,7083,1,4,0)
 ;;=4^K21.0
 ;;^UTILITY(U,$J,358.3,7083,2)
 ;;=^5008504
 ;;^UTILITY(U,$J,358.3,7084,0)
 ;;=K30.^^58^465^3
 ;;^UTILITY(U,$J,358.3,7084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7084,1,3,0)
 ;;=3^Functional Dyspepsia
 ;;^UTILITY(U,$J,358.3,7084,1,4,0)
 ;;=4^K30.
 ;;^UTILITY(U,$J,358.3,7084,2)
 ;;=^5008558
 ;;^UTILITY(U,$J,358.3,7085,0)
 ;;=K50.911^^58^465^1
 ;;^UTILITY(U,$J,358.3,7085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7085,1,3,0)
 ;;=3^Crohn's Disease w/ Rectal Bleeding,Unspec
 ;;^UTILITY(U,$J,358.3,7085,1,4,0)
 ;;=4^K50.911
 ;;^UTILITY(U,$J,358.3,7085,2)
 ;;=^5008646
 ;;^UTILITY(U,$J,358.3,7086,0)
 ;;=K51.80^^58^465^10
 ;;^UTILITY(U,$J,358.3,7086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7086,1,3,0)
 ;;=3^Ulcerative Colitis w/o Complications NEC
 ;;^UTILITY(U,$J,358.3,7086,1,4,0)
 ;;=4^K51.80
 ;;^UTILITY(U,$J,358.3,7086,2)
 ;;=^5008687
 ;;^UTILITY(U,$J,358.3,7087,0)
 ;;=K51.819^^58^465^8
 ;;^UTILITY(U,$J,358.3,7087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7087,1,3,0)
 ;;=3^Ulcerative Colitis w/ Unspec Complications
 ;;^UTILITY(U,$J,358.3,7087,1,4,0)
 ;;=4^K51.819
 ;;^UTILITY(U,$J,358.3,7087,2)
 ;;=^5008693
